Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer (MRSI+RRP)
Imaging Prostatic Lipids to Distinguish Aggressive Prostate Cancer
Sponsor: OHSU Knight Cancer Institute
This observational or N/A phase trial investigates Prostate Cancer and is currently completed. OHSU Knight Cancer Institute leads this study, which shows 11 recorded versions since 2013 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 6 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
May 2017 — Aug 2017 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2017 — May 2017 [monthly]
Active Not Recruiting NA
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- OHSU Knight Cancer Institute
- Oregon Health and Science University
- Portland VA Medical Center
- United States Department of Defense
For direct contact, visit the study record on ClinicalTrials.gov .